Topic: Intercompany Technical Collaborations: How Unethical Patent Prosecution Practices Can Devalue Patent Portfolios
Presenter: Juanita Brooks, Fish & Richardson
Date: Tuesday, November 16
Time: 6 – 8 pm
Location: Fish & Richardson, 12860 El Camino Real, Suite 400, San Diego, CA 92130
Please join us as Juanita Brooks discusses how unethical patent prosecution practices can devalue patent portfolios within the context of intercompany technical collaborations.
Please join us for this in-person meeting. The SDIPLA Board is monitoring CDC recommendations. We will have an open-air reception with food/drinks from 6:00-6:45 pm where masks will be optional. The 6:45 pm presentation will be indoors, and we will ask attendees to wear masks during the presentation. PLEASE NOTE THAT WE WILL ASK ALL ATTENDEES TO SIGN A FORM UPON ARRIVAL TO THE EVENT ATTESTING THAT THEY ARE FULLY VACCINATED AGAINST COVID-19.
About our speaker:
Juanita R. Brooks is a nationally recognized trial and appellate attorney who focuses on complex intellectual property, product liability, and mass tort litigation. She is an innovative, formidable litigator with a demonstrated, near-perfect winning record in complex, high-stakes lawsuits that few trial attorneys can match.
A master storyteller, Ms. Brooks paints pictures with words to explain the complex technologies at the center of her matters to judges and juries in a way that is both understandable and compelling and will be remembered throughout the trial. Law360 named her an “Icon of IP” for her “skill at trying complicated patent cases without getting bogged down in the technical weeds” and said she is a “jury whisperer.” She has also been heralded by the American Lawyer as “a titan of the patent bar” upon receiving its “Litigator of the Year” honors.
Her skill at connecting with courtroom audiences has made her a go-to litigator when the stakes are high for companies that range from startups to Fortune 10 corporations. Ms. Brooks’ successes in patent litigation have protected billions of dollars in sales for her clients and have helped define the ever-evolving landscape of patent and IP law. Her clients represent a cross-section of cutting-edge industries including software, medical device, pharmaceutical, and electronics.